Ceva

Ceva operates within the Pharmaceuticals and Healthcare sectors, focusing on animal health solutions. The company employs between 1,000 and 5,000 individuals, indicating a significant workforce dedicated to its operations. With a revenue of $573.9M, Ceva demonstrates substantial market presence and financial capacity within its industry. Its product portfolio includes veterinary pharmaceuticals, vaccines, and diagnostic support, aimed at enhancing animal well-being and disease prevention across livestock, poultry, and companion animals. The company's commitment extends to a global community, suggesting a broad operational reach and impact.

As a key player in animal health, Ceva leverages its expertise in biologicals and vaccine technology to address critical challenges in veterinary medicine. The company's B2B focus is supported by a robust team, and you can Meet Ceva's team to understand the leadership and expertise driving its innovation. Their product development spans areas like reproduction, disease control, and the provision of essential aids for veterinarians and animal care professionals. This comprehensive approach underscores their dedication to advancing animal welfare and public health through science-driven solutions.

Ceva's strategic positioning is further highlighted by its engagement in various markets, as suggested by hashtags indicating presence in North America, Europe, and Asia. The company's efforts contribute to the global effort in safeguarding animal health, which in turn supports food security and human well-being. Through continuous research and development, Ceva aims to provide effective and accessible solutions for a wide range of animal health needs, solidifying its role as a leader in the veterinary pharmaceutical landscape.